Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Risk Assessment Tool for Estimating 10-year Risk of Developing Hard CHD (Myocardial Infarction and Coronary Death)
The risk assessment tool below uses recent data from the Framingham Heart Study to estimate 10-year risk for “hard” coronary heart disease outcomes (myocardial infarction and coronary death). This tool is designed to estimate risk in adults aged 20 and older who do not have heart disease or diabetes. Use the calculator below to estimate 10-year risk.
Age: years
Gender:
Total Cholesterol: mg/dL
HDL Cholesterol: mg/dL
Smoker:
Systolic Blood Pressure: mm/Hg
Currently on any medication to treat high blood pressure.


top
Total cholesterol - Total cholesterol values should be the average of at least two measurements obtained from lipoprotein analysis.
top
HDL cholesterol - HDL cholesterol values should be the average of at least two measurements obtained from lipoprotein analysis.
top
Smoker - The designation “smoker” means any cigarette smoking in the past month.
top
Systolic blood pressure - The blood pressure value used is that obtained at the time of assessment, regardless of whether the person is on antihypertensive therapy (treated hypertension carries residual risk).
top
More Information - Determining 10-year (short term) risk for developing CHD is carried out using Framingham risk scoring. The risk factors included in the Framingham calculation are age, total cholesterol, HDL cholesterol, systolic blood pressure, treatment for hypertension, and cigarette smoking. Because of a larger database, Framingham estimates are more robust for total cholesterol than for LDL cholesterol. Note, however, that LDL cholesterol remains the primary target of therapy. The Framingham risk score gives estimates for “hard CHD” which includes myocardial infarction and coronary death.

ATP III Home | NCEP Home | NHLBI Home | NIH Home

NCEP Logo National Cholesterol Education Program